Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

Estetrol (E4) is a natural estrogenic steroid that is normally produced by human fetal liver.
Recent research has demonstrated that it is a potent, orally bioavailable, natural selective …

Objective To provide a comprehensive overview of the risk of venous thrombosis in women
using different combined oral contraceptives. Design Systematic review and network meta …

Introduction The coronavirus disease (COVID-19) is a global health emergency. Major
disruption to healthcare services during the current COVID-19 pandemic will last even after …

Estrogen-containing medication, prescribed either for contraception in women of
reproductive age or for prevention of cardiovascular events and osteoporosis as well as for …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …

For many years, it has been well documented that combined hormonal contraceptives
increase the risk of venous thromboembolism (VTE). The third-generation pill use …

Background The transgender population that uses gender‐affirming hormone therapy
(GAHT) is rapidly growing. The (side) effects of GAHT are largely unknown. We examined …

Objectives Estetrol (E 4) is a natural estrogen produced by the human fetal liver. In
combination with drospirenone (DRSP) or levonorgestrel (LNG), E 4 blocks ovulation and …

The risk of venous thrombosis (VT) varies according to the type of progestogen that is found
in combined oral contraceptives (COCs). When combined with the estrogen component …